These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38565508)

  • 21. Progressive myoclonic epilepsy.
    Satishchandra P; Sinha S
    Neurol India; 2010; 58(4):514-22. PubMed ID: 20739785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all.
    Delgado-Escueta AV; Bourgeois BF
    Epilepsia; 2008 Dec; 49 Suppl 9():13-24. PubMed ID: 19087113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis of familial adult myoclonic epilepsy.
    Baykan B; Franceschetti S; Canafoglia L; Cavalleri GL; Michelucci R; Scheffer IE
    Epilepsia; 2023 Jun; 64 Suppl 1():S52-S57. PubMed ID: 36751956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ILAE Genetics Literacy series: Progressive myoclonus epilepsies.
    Cameron JM; Ellis CA; Berkovic SF; ;
    Epileptic Disord; 2023 Oct; 25(5):670-680. PubMed ID: 37616028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive myoclonus epilepsies: clinical and genetic aspects.
    Berkovic SF; Cochius J; Andermann E; Andermann F
    Epilepsia; 1993; 34 Suppl 3():S19-30. PubMed ID: 8500430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DRPLA: An unusual disease or an underestimated cause of ataxia in Brazil?
    Pinto WBVR; Salomão RPA; Bergamasco NC; da Cunha Ribas G; da Graça FF; Lopes-Cendes I; Bonadia L; de Souza PVS; Bulle Oliveira AS; Saraiva-Pereira ML; Jardim LB; Tumas V; Junior WM; França MC; Pedroso JL; Barsottini OGP; Teive HAG
    Parkinsonism Relat Disord; 2021 Nov; 92():67-71. PubMed ID: 34700111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in evoked potential characteristics between DRPLA patients and patients with progressive myoclonic epilepsy: preliminary findings indicating usefulness for differential diagnosis.
    Kasai K; Onuma T; Kato M; Kato T; Takeya J; Sekimoto M; Watanabe K; Minami N; Goto Y; Minabe Y
    Epilepsy Res; 1999 Oct; 37(1):3-11. PubMed ID: 10515170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortico-muscular coherence and brain networks in familial adult myoclonic epilepsy and progressive myoclonic epilepsy.
    Franceschetti S; Visani E; Panzica F; Coppola A; Striano P; Canafoglia L
    Clin Neurophysiol; 2023 Jul; 151():74-82. PubMed ID: 37216715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
    Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
    Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG-EMG relationship estimated using autoregressive models.
    Panzica F; Canafoglia L; Franceschetti S; Binelli S; Ciano C; Visani E; Avanzini G
    Clin Neurophysiol; 2003 Jun; 114(6):1041-52. PubMed ID: 12804673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence of Unverricht-Lundborg disease and congenital deafness: molecular resolution of a complex comorbidity.
    Kecmanović M; Ristić AJ; Sokić D; Keckarević-Marković M; Vojvodić N; Ercegovac M; Janković S; Keckarević D; Savić-Pavićević D; Romac S
    Epilepsia; 2009 Jun; 50(6):1612-5. PubMed ID: 19170735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive myoclonus epilepsies: EPM1, EPM2A, EPM2B.
    Chan EM; Andrade DM; Franceschetti S; Minassian B
    Adv Neurol; 2005; 95():47-57. PubMed ID: 15508913
    [No Abstract]   [Full Text] [Related]  

  • 34. Progressive myoclonic epilepsy: A clinical, electrophysiological and pathological study from South India.
    Sinha S; Satishchandra P; Gayathri N; Yasha TC; Shankar SK
    J Neurol Sci; 2007 Jan; 252(1):16-23. PubMed ID: 17166519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances.
    Zimmern V; Minassian B
    Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unverricht-Lundborg disease.
    Crespel A; Ferlazzo E; Franceschetti S; Genton P; Gouider R; Kälviäinen R; Korja M; Lehtinen MK; Mervaala E; Simonato M; Vaarmann A
    Epileptic Disord; 2016 Sep; 18(S2):28-37. PubMed ID: 27582036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis.
    Berkovic SF; So NK; Andermann F
    J Clin Neurophysiol; 1991 Jul; 8(3):261-74. PubMed ID: 1918332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations.
    Canafoglia L; Gennaro E; Capovilla G; Gobbi G; Boni A; Beccaria F; Viri M; Michelucci R; Agazzi P; Assereto S; Coviello DA; Di Stefano M; Rossi Sebastiano D; Franceschetti S; Zara F
    Epilepsia; 2012 Dec; 53(12):2120-7. PubMed ID: 23205931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a human induced pluripotent stem cell line (UEFi004-A) from a patient with progressive myoclonic epilepsy type 1 (EPM1).
    Singh S; Plotnikova L; Karvonen K; Ryytty S; Hyppönen J; Kälviäinen R; Hämäläinen RH
    Stem Cell Res; 2023 Dec; 73():103248. PubMed ID: 37951142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.